Form 4: Health Catalyst Chief People Officer Executes Non-Discretionary Stock Sale for Tax Obligations

Health Catalyst, Inc.'s Chief People Officer, Linda Llewelyn, disposed of 2,965 shares of common stock on June 2, 2025, solely to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Summary

• Linda Llewelyn, Chief People Officer of Health Catalyst, Inc. (HCAT), reported a transaction on June 2, 2025.
• The transaction involved the disposition of 2,965 shares of Health Catalyst Common Stock.
• The shares were sold at a price of $3.6348 per share.
• This sale was a 'sell to cover' transaction, mandated by the Issuer's equity incentive plans to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs).
• The transaction does not represent a discretionary trade by the Reporting Person.
• Following this reported transaction, Linda Llewelyn beneficially owns 155,879 shares of Health Catalyst Common Stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral. A Form 4 detailing a 'sell to cover' transaction for tax purposes upon RSU vesting is a routine event and does not typically indicate positive or negative sentiment regarding the company's performance or outlook. It's a standard administrative process for equity compensation.

Positives

• The transaction indicates the vesting of Restricted Stock Units (RSUs) for the Chief People Officer, which is a positive event for the employee as it represents compensation becoming exercisable.

Negatives

• The disposition of shares, while non-discretionary, reduces the direct ownership stake of a key executive, though this is a standard practice for tax purposes upon RSU vesting.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Management Comments

• "Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units."
• "This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary trade by the Reporting Person."

Industry Context

This specific Form 4 filing details a routine, non-discretionary stock transaction by a corporate officer, which is a common occurrence across publicly traded companies when equity compensation, such as Restricted Stock Units (RSUs), vests. It does not provide broader industry trends or competitive insights.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes, not indicative of a change in management's confidence or a significant shift in ownership structure.
• Employees: The vesting of RSUs, which led to this transaction, is a positive for the employee (Linda Llewelyn) as it represents the realization of equity compensation.

Key Dates

Keywords

Health Catalyst, HCAT, SEC Form 4, Insider Transaction, Stock Sale, Restricted Stock Units, RSU Vesting, Tax Withholding, Corporate Officer